U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers
BioSample: SAMN16304059; Sample name: Res13-Croi-PEA17-28
Organism
Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
collected byAgriculture and Agri-Food Canada
collection date2017-10-30
geographic locationCanada: Quebec
isolation sourcefeces
latitude and longitudemissing
hostSus scrofa domesticus
host diseasemissing
serotypeO-untypeable:H4 (99.05)
strainRes13-Croi-PEA17-28
BioProject
PRJNA662792 Escherichia coli
Retrieve all samples from this project

Submission
Agriculture and Agri-Food Canada, Jean-Simon Brouard; 2020-09-30
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
ampicillinresistant>32mg/LMICSensititerCLSI
azithromycinsusceptible==4mg/LMICSensititerCLSI
cefoxitinresistant>64mg/LMICSensititerCLSI
ceftriaxoneresistant==64mg/LMICSensititerCLSI
chloramphenicolsusceptible==4mg/LMICSensititerCLSI
ciprofloxacinsusceptible<=1mg/LMICSensititerCLSI
gentamicinsusceptible<=4mg/LMICSensititerCLSI
meropenemsusceptible<=1mg/LMICSensititerCLSI
nalidixic acidsusceptible==2mg/LMICSensititerCLSI
streptomycinsusceptible==8mg/LMICSensititerCLSI
sulfisoxazolesusceptible<=16mg/LMICSensititerCLSI
tetracyclineresistant>32mg/LMICSensititerCLSI
amoxicillin-clavulanic acidresistant>32/1mg/LMICSensititerCLSI
piperacillin-tazobactamsusceptible==8/1mg/LMICSensititerCLSI
cefazolinresistant>16mg/LMICSensititerCLSI
cephalothinresistant>16mg/LMICSensititerCLSI
cefotaximeresistant==16mg/LMICSensititerCLSI
cefpodoximeresistant>32mg/LMICSensititerCLSI
ceftazidimeresistant==32mg/LMICSensititerCLSI
cefotaxime-clavulanic acidnot defined==16/1mg/LMICSensititerCLSI
ceftazidime-clavulanic acidnot defined==16/1mg/LMICSensititerCLSI
cefepimesusceptible<=1mg/LMICSensititerCLSI
imipenemsusceptible<=0.5mg/LMICSensititerCLSI
trimethoprim-sulfamethoxazolesusceptible<=0.12/1mg/LMICSensititerCLSI
Accession:
SAMN16304059
ID:
16304059

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center